Spyre Therapeutics, Inc. (SYRE)

Spyre Therapeutics Revenue

In the year 2023, Spyre Therapeutics had annual revenue of $886.00K, a decrease of -61.96%.

• Revenue (ttm): $886.00K
• Revenue Growth: -61.96%
• P/S Ratio: 1,369.33
• Revenue / Employee: $29,533
• Employees: 30
• Market Cap: 1.21B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	886.00K	-1.44M	-61.96%
Dec 31, 2022	2.33M	-16.41M	-87.57%
Dec 31, 2021	18.74M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	3.89M	-1.32M	-25.30%
Dec 31, 2017	5.21M	577.00K	12.47%
Dec 31, 2016	4.63M	-1.46M	-23.94%
Dec 31, 2015	6.09M	-	-
Dec 31, 2014	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.